Teleflex Incorporated Common Stock (TFX)

131.68
+8.45 (6.86%)
NYSE · Last Trade: May 7th, 6:36 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close123.23
Open129.62
Bid118.00
Ask138.25
Day's Range127.02 - 136.30
52 Week Range100.18 - 139.67
Volume1,349,617
Market Cap6.16B
PE Ratio (TTM)-6.408
EPS (TTM)-20.6
Dividend & Yield1.360 (1.03%)
1 Month Average Volume952,428

Chart

About Teleflex Incorporated Common Stock (TFX)

Teleflex Inc is a global provider of medical technology products that enhance the ability of healthcare professionals to provide high-quality patient care. The company develops a wide range of innovative solutions across various medical specialties, including surgical, critical care, and respiratory applications. Teleflex focuses on the design, manufacturing, and commercialization of devices and instruments that improve procedural outcomes, facilitate patient recovery, and enhance safety in both hospital and outpatient settings. With a commitment to advancing medical technologies, Teleflex aims to meet the evolving needs of healthcare providers and patients worldwide. Read More

News & Press Releases

Why Is Teleflex (TFX) Stock Rocketing Higher Today
What Happened? Shares of medical technology company Teleflex (NYSE:TFX) jumped 9.2% in the afternoon session after the company reported first-quarter 2026 fi...
Via StockStory · May 7, 2026
Teleflex (TFX) Q1 2026 Earnings Transcriptfool.com
Teleflex (TFX) Q1 2026 Earnings Transcript
Via The Motley Fool · May 7, 2026
Teleflex (NYSE:TFX) Beats Q1 CY2026 Sales Expectations
Medical technology company Teleflex (NYSE:TFX) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 32.3% year on year to $54...
Via StockStory · May 7, 2026
Teleflex (NYSE:TFX) Beats Q1 Estimates and Guides In Line, Stock Surges Pre-Marketchartmill.com
Via Chartmill · May 7, 2026
Teleflex Inc. (NYSE:TFX) Shares Drop as Q4 Earnings and 2026 Outlook Miss Estimates Amid Major Divestiture Planchartmill.com
Via Chartmill · February 26, 2026
Teleflex Reports First Quarter Financial Results and Full Year 2026 Outlook
Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the first quarter ended March 31, 2026.
By Teleflex Incorporated · Via Business Wire · May 7, 2026
Teleflex Earnings: What To Look For From TFX
Medical technology company Teleflex (NYSE:TFX) will be reporting earnings this Thursday morning. Here’s what investors should know. Teleflex missed analysts’...
Via StockStory · May 5, 2026
This Fund Disclosed Selling $18 Million in Alphatec Last Quarter. The Stock Just Tanked 20% After Earningsfool.com
This medical technology firm provides spinal surgery solutions to U.S. hospitals and surgical centers through proprietary devices.
Via The Motley Fool · May 5, 2026
Western Standard Sells Entire Select Medical Position Ahead of $3.9 Billion Buyoutfool.com
Select Medical Holdings delivers rehabilitation and occupational health services through a nationwide network of hospitals and clinics.
Via The Motley Fool · May 5, 2026
3 Unpopular Stocks We Keep Off Our Radar
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t...
Via StockStory · May 4, 2026
Teleflex Appoints Jason Weidman as President and CEO
Teleflex Incorporated (NYSE: TFX) today announced that Jason Weidman has been appointed President and Chief Executive Officer, effective June 8, 2026. He will succeed Stuart Randle, who has been serving as Interim President and CEO since January 2026 and will continue as a member of Teleflex’s Board of Directors. Mr. Weidman is expected to join the Teleflex Board when he assumes his role as President and CEO.
By Teleflex Incorporated · Via Business Wire · April 30, 2026
Teleflex (TFX) Q4 2024 Earnings Transcriptfool.com
Teleflex (TFX) Q4 2024 Earnings Transcript
Via The Motley Fool · April 22, 2026
The Teleflex Pivot: Inside the $1 Billion Share Buyback and Strategic Breakup
Disclaimer: This content is intended for informational purposes only and is not financial advice. Today’s date is April 9, 2026. Introduction In the high-stakes arena of medical technology, few stories are as dramatic as the current transformation of Teleflex Incorporated (NYSE: TFX). Once a darling of the "growth-at-any-cost" era, the Wayne, Pennsylvania-based company found itself [...]
Via Finterra · April 9, 2026
A Look Back at Surgical Equipment & Consumables - Specialty Stocks’ Q4 Earnings: Teleflex (NYSE:TFX) Vs The Rest Of The Pack
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...
Via StockStory · April 5, 2026
3 Unprofitable Stocks with Questionable Fundamentals
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to conv...
Via StockStory · March 30, 2026
Why Teleflex (TFX) Stock Is Up Today
What Happened? Shares of medical technology company Teleflex (NYSE:TFX) jumped 4.2% in the afternoon session after an activist shareholder urged the company ...
Via StockStory · March 27, 2026
Teleflex Reiterates Commitment to Value Maximizing Strategies and Strong Execution
Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today issued the following statement in response to the press release issued by Irenic Capital Management L.P. (“Irenic”).
By Teleflex Incorporated · Via Business Wire · March 27, 2026
3 Small-Cap Stocks with Warning Signs
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...
Via StockStory · March 23, 2026
Medical Technology Alert: BSX, TFX, ARAY, CSDX, NDRA Emerging Across Cancer Treatment and GLP-1 Healthcare Ecosystems
The global absorbable hydrogel tissue spacer market, used primarily in prostate cancer radiation therapy , is gaining momentum as healthcare providers increasingly adopt technologies designed to reduce treatment side effects while improving patient outcomes.
Via AB Newswire · March 11, 2026
3 Reasons TFX is Risky and 1 Stock to Buy Instead
Over the last six months, Teleflex’s shares have sunk to $113.26, producing a disappointing 13% loss - a stark contrast to the S&P 500’s 4.8% gain. This was ...
Via StockStory · March 9, 2026
Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea...
Via StockStory · March 6, 2026
Teleflex (TFX) Q4 2025 Earnings Call Transcriptfool.com
Teleflex (TFX) Q4 2025 Earnings Call Transcript
Via The Motley Fool · February 26, 2026
Teleflex (NYSE:TFX) Misses Q4 CY2025 Sales Expectations, Stock Drops
Medical technology company Teleflex (NYSE:TFX) missed Wall Street’s revenue expectations in Q4 CY2025, with sales falling 28.5% year on year to $569 million. Its non-GAAP profit of $1.93 per share was 48.4% below analysts’ consensus estimates.
Via StockStory · February 26, 2026
Teleflex Announces Quarterly Dividend
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable March 31, 2026, to shareholders of record at the close of business on March 6, 2026. Additional information about Teleflex can be obtained from the company’s website at teleflex.com.
By Teleflex · Via Business Wire · February 26, 2026
Teleflex Reports 2025 Financial Results and Full Year 2026 Outlook
Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the year ended December 31, 2025.
By Teleflex Incorporated · Via Business Wire · February 26, 2026